The Firmwatch take
Saturn Biosciences Ltd (06977779) currently shows: Watch signal detected, based on accounts to 31 July 2025; last refreshed 24 May 2026. A strike-off notice has been published. The company can still trade until the second gazette.
Companies House source·Accounts to 31 Jul 2025·Refreshed 24 May 2026·Methodology and caveats
Firmwatch signals are generated from public filings and are not credit ratings or financial advice.
1 public risk event on file
Pulse · Net assets, 2024–2025
↗ £116Incorporated
31 July 2009
16 years on the register
Sector
Scientific research and development
SIC 72110 · matched to division
Size
Not classified
Net assets
£5k
£5,161
Cash at bank
Not disclosed
Not required for this filing type
Risk events
1 on file
Public Gazette / Companies House
Analytics
Risk, value and sector comparison
Insolvency risk
38/100
watch risk
Estimated public-data value
£3,871 - £6,967
medium confidence - net asset range
Sector comparison
Sector benchmark not available yet. This appears when the company has SIC data and enough imported peer accounts.
Thin net asset buffer
The company reports a small visible net asset position.
Limited working capital
The short-term asset buffer is positive but small.
Weak current ratio
Current assets are less than 75% of current liabilities.
Risk and value are estimates from public accounts only. They are not a credit score, valuation opinion or insolvency prediction guarantee. See methodology.
Balance sheet
Full extracted balance sheet
Cash at bank
Bank balances disclosed in the public accounts.
Not disclosed
Current assets
Assets expected to turn into cash within one year.
£201
Current liabilities
Amounts due within one year (short-term creditors).
£5,162
Working capital
Current assets minus current liabilities.
£4,961
Fixed assets
Long-term tangible and intangible assets.
Not disclosed
Total assets less current liabilities
Fixed assets plus working capital.
£4,961
Net assets
What's left after liabilities are deducted from assets.
£5,161
Equity (capital & reserves)
Shareholder funds.
£5,161
Figures extracted from the company's public XBRL/iXBRL filing. Fields shown as Not disclosed are not legally required for this filing type and are absent from the source document — they are not necessarily zero.
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.